💡 本文重點導覽
- How insulin resistance drives PCOS
- The metabolic features of PCOS
- Addressing PCOS through dietary structure
📋 本文重點摘要
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women — and insulin resistance is its primary driver, not ovarian dysfunction. This article explains the metabolic mechanism behind PCOS and why addressing insulin sensitivity is central to treatment.
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women — and insulin resistanc…
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women, affecting 8–13% globally. It is classified as a gynecological condition and commonly treated with hormonal contraceptives — but this approach addresses symptoms without touching the metabolic root cause. In 65–80% of PCOS cases, insulin resistance is the primary driver. Treating PCOS without addressing insulin sensitivity is treating the downstream manifestation of an upstream metabolic problem.
How insulin resistance drives PCOS
In insulin resistance, chronically elevated insulin levels stimulate the ovaries’ theca cells to produce excess androgens (primarily testosterone and androstenedione). These androgens disrupt follicle development, preventing normal ovulation and leading to the accumulation of small, arrested follicles that appear as “polycystic” on ultrasound. Elevated insulin also reduces sex hormone-binding globulin (SHBG) production in the liver, increasing free testosterone levels and amplifying androgenic symptoms: acne, hirsutism, and hair loss. The ovaries are responding normally to an abnormal hormonal signal driven by metabolic dysfunction.
The metabolic features of PCOS
Women with PCOS have a significantly higher prevalence of metabolic syndrome compared to age-matched women without PCOS — approximately 33% vs. 8%. They have higher rates of type 2 diabetes (lifetime risk up to 40%), cardiovascular disease, and non-alcoholic fatty liver disease. These aren’t coincidental associations; they’re consequences of the shared root mechanism of insulin resistance. BMI doesn’t predict PCOS risk reliably: lean women with insulin resistance develop PCOS at significant rates, while some obese women do not — confirming that insulin sensitivity, not weight, is the primary driver.
Addressing PCOS through dietary structure
Low-glycemic dietary patterns that improve insulin sensitivity consistently improve PCOS outcomes — including menstrual regularity, androgen levels, and fertility — in clinical trials. This includes reducing refined carbohydrates, increasing fiber, and distributing protein across meals. CNFCD is a science-based dietary coaching method developed by Weikang. Hsien-Hung Shih (ResetWith) provides dietary consultation using CNFCD for clients with PCOS and other insulin resistance-related conditions.
CNFCD provides dietary and lifestyle guidance only. It does not replace medical diagnosis or treatment. Please consult your physician if you have health concerns.
👉 Ready to address your metabolic health through diet? Feel free to reach out for an initial consultation.
— Hsien-Hung Shih | ResetWith Health Coach | cnfcd.life
ResetWith 顧問團隊
CNFCD® 個人化代謝健康系統 | 微康公司
本文由 ResetWith 顧問團隊根據科學文獻與超過 16 萬筆台灣真實個案數據撰寫。所有內容以 CNFCD® 方法論為基礎,供健康參考使用。
發布:2026年4月16日 最後更新:2026年6月3日
Recommended next reads
Author, Review, and Health Content Note
Publisher: ResetWith consulting team. Principal consultant: Pangpang / Sean Shih. Last updated: 2026-06-03.
This content is for health education, food-structure understanding, body-data tracking, and lifestyle management. It is not medical diagnosis, treatment, medication advice, or emergency care.
Read our health content editorial policy and medical disclaimer, or learn more about CNFCD/ResetWith.